Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride Capsules
NCT04967443
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Heart Failure
Interventions
DRUG:
Prazosin HCl 2mg
DRUG:
Prazosin HCl 1 mg
DRUG:
Prazosin HCl 5 mg
Sponsor
Pfizer